Clinical trial
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical…
NCT00002921 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00002921 |
|---|---|
| Title | S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery |
| Official title | Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adrenocortical Carcinoma |
| Intervention type | Drug |
| Interventions | suramin, therapeutic hydrocortisone |
| Enrollment | 13 |
| Start date | Mar 1, 1997 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Jul 30, 2004 |
| Last update posted | Oct 5, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: